Ibuprofen Toxicity
- PMID: 30252334
- Bookshelf ID: NBK526078
Ibuprofen Toxicity
Excerpt
Ibuprofen, 2-(4-isobutylphenyl) propionic acid, belongs to the class of nonsteroidal anti-inflammatory drugs (NSAIDs) and was discovered by Dr. Stewart Adams in 1961. The drug was first marketed in 1969 in the United Kingdom and in 1974 in the United States. Ibuprofen is commonly prescribed as an analgesic, antipyretic, and anti-inflammatory agent in conditions such as osteoarthritis, rheumatoid arthritis, juvenile idiopathic arthritis, and acute musculoskeletal pain. Off-label applications include its use in conditions such as cystic fibrosis to slow progression. Ibuprofen is also used to close patent ductus arteriosus in neonates. This resource serves to review ibuprofen's essential pharmacological characteristics, clinical presentations during an overdose, and management of ibuprofen toxicity.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- Halford GM, Lordkipanidzé M, Watson SP. 50th anniversary of the discovery of ibuprofen: an interview with Dr Stewart Adams. Platelets. 2012;23(6):415-22. - PubMed
-
- Konstan MW, VanDevanter DR, Sawicki GS, Pasta DJ, Foreman AJ, Neiman EA, Morgan WJ. Association of High-Dose Ibuprofen Use, Lung Function Decline, and Long-Term Survival in Children with Cystic Fibrosis. Ann Am Thorac Soc. 2018 Apr;15(4):485-493. - PubMed
-
- Yeung T, Shahroor M, Jain A, Weisz D, Jasani B. Efficacy and safety of high versus standard dose ibuprofen for patent ductus arteriosus treatment in preterm infants: A systematic review and meta-analysis. J Neonatal Perinatal Med. 2022;15(3):501-510. - PubMed
Publication types
LinkOut - more resources
Full Text Sources